Veronesi Paolo, Rodriguez-Fernandez Julia, Intra Mattia
Division of Breast Surgery, European Institute of Oncology, Milan, Italy.
Breast. 2007 Dec;16 Suppl 2:S67-70. doi: 10.1016/j.breast.2007.07.009. Epub 2007 Aug 13.
In the past 10 years, sentinel lymph node biopsy (SLNB) has become a safe and accurate method for axillary staging. Several recent publications worldwide have been progressively elucidating old controversies. The list of clinical scenarios in which SLNB was initially contraindicated seems to be dwindling as experience with this technique increases. Here we discuss the suitability of SLNB in the settings of microinvasive cancer, after breast or axillary surgery and after neoadjuvant chemotherapy.
在过去10年中，前哨淋巴结活检（SLNB）已成为一种安全、准确的腋窝分期方法。最近全球范围内的一些出版物逐渐阐明了过去的争议。随着对该技术经验的增加，最初被视为SLNB禁忌的临床情况列表似乎在减少。在此，我们讨论SLNB在微浸润癌、乳房或腋窝手术后以及新辅助化疗后的适用性。
